During the past decade, LSU Healthcare Network conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LSU Healthcare Network" are "Hepatitis C" (1 trials), "Hepatitis C, Chronic" (1 trials), "Hyperphosphatemia" (1 trials) and "Upper Limb Spasticity" (1 trials). Many other conditions were trialed in "LSU Healthcare Network" in a lesser frequency.

Most popular intervention types in "LSU Healthcare Network" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "AboBoNT-A" (1 trials), "OnaBoNT-A" (1 trials), "PEGinterferon alfa-2a" (1 trials) and "thymalfasin (thymosin alpha 1)" (1 trials). Other intervention names were less common.

The vast majority of trials in "LSU Healthcare Network" are 3 trials for "All" genders.

Currently, there are NaN active trials in "LSU Healthcare Network". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in LSU Healthcare Network, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LSU Healthcare Network, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".